CASC4 Antikörper (C-Term)
Kurzübersicht für CASC4 Antikörper (C-Term) (ABIN951049)
Target
Alle CASC4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 343-373, C-Term
-
Spezifität
- This antibody reacts to CASC4.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human and Mouse.
-
Aufreinigung
- Affinity chromatography on Protein A
-
Immunogen
- KLH conjugated synthetic peptide between 343-373 amino acids from the C-terminal region of human CASC4
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS, 0.09 % (W/V) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CASC4 (Cancer Susceptibility Candidate 4 (CASC4))
-
Andere Bezeichnung
- CASC4
-
Hintergrund
- The increased expression level of this gene is associated with HER-2/neu proto-oncogene overexpression. Amplification and resulting overexpression of this proto-oncogene are found in approximately 30 % of human breast and 20 % of human ovarian cancers. Further characterization of the product of this gene may yield insight into the fundamental biology and pathogenetic effects of HER-2/neu overexpression in human breast and ovarian cancer cells. Alternatively spliced variants encoding different isoforms have been identified for this gene.Synonyms: Cancer susceptibility candidate gene 4 protein
-
Molekulargewicht
- 48864 Da
-
Gen-ID
- 113201
-
NCBI Accession
- NP_612432
Target
-